Skip to content

Contraception Decision Aid Use and Patient Outcomes

Contraception Decision Aid Use and Patient Outcomes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05177783
Enrollment
500
Registered
2022-01-05
Start date
2022-01-15
Completion date
2022-08-30
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraceptive Usage

Brief summary

The purpose of this study is to assess the impact of a contraception decision aid mobile application on: (a) decisional conflict, (b) reproductive health self-efficacy, (c) contraceptive and reproductive health literacy, and (d) contraceptive use intentions.

Detailed description

After being informed about the study and the potential risks, all participants giving written informed consent will be randomly assigned in a double-blind manner (participant and investigator) in a 1:1 ratio to complete an interactive contraception decision aid health questionnaire (Tuune) or a standard medical questionnaire (Control). After, all participants will be asked questions assessing: (a) decisional conflict, (b) reproductive health self-efficacy, (c) contraceptive and reproductive health literacy, and (d) contraceptive use intentions.

Interventions

BEHAVIORALTuune health questionnaire

Participants complete the Tuune contraceptive decision aid health questionnaire.

BEHAVIORALControl health questionnaire

Participants complete a standard physician intake health questionnaire.

Sponsors

Texas Christian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

Participants will be condition-blind (i.e., they will not be told whether the health application they use is the treatment or control application). Assignment to treatment arms will be randomized using Qualtrics Experimental Software and treatment assignment group will remain masked to the investigator and those in charge of data analysis until after data analysis is complete.

Intervention model description

Parallel

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 34 Years
Healthy volunteers
Yes

Inclusion criteria

* Females 18 to 34 years of age who enroll to participate in the study, which will take place on the campus of Texas Christian University.

Exclusion criteria

* Women who are currently pregnant or breastfeeding. * Women who wish to become pregnant within the next 12 months.

Design outcomes

Primary

MeasureTime frameDescription
Decisional ConflictImmediately upon completion of the assigned health questionnaire.Decisional conflict about contraceptive use will be measured using a modified version of the Traditional Decisional Conflict Scale to assess decisional conflict about birth control use. The modified version of this scale is a 13-item measure utilizing a 1-7 rating scale (1 = strongly disagree \| 7 = strongly agree) asking participants about their decisional conflict with respect to birth control. Higher scores on this scale indicate less decisional conflict about birth control use. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: O'Connor AM (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25-30. doi: 10.1177/0272989X9501500105.
Reproductive Health Self-EfficacyImmediately upon completion of the assigned health questionnaire.Reproductive health self-efficacy will be measured using a modified version of the Menstrual Attitudes Questionnaire. The modified version is a 9-item measure utilizing a 1-7 rating scale (1 = strongly disagree \| 7 = strongly agree) asking participants about their menstrual cycle and hormonal self-efficacy. Higher scores indicate lower reproductive health self-efficacy. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: Brooks-Gunn, J., & Ruble, D. N. (1980). The Menstrual Attitude Questionnaire. Psychosomatic Medicine, 42(5), 503-512. https://doi.org/10.1097/00006842-198009000-00005
Reproductive Health and Contraceptive KnowledgeImmediately upon completion of the assigned health questionnaire.Reproductive health and contraceptive knowledge will be measured using the following 6-item, 1-7 rating scale (1 = strongly disagree \| 7 = strongly agree). Higher scores indicate greater reproductive health and contraceptive knowledge. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/
Contraceptive Use IntentionsImmediately upon completion of the assigned health questionnaire.Contraceptive use intentions will be measured by asking participants to rate their likelihood of using hormonal birth control in the next week, month, and year. Each question will be measured on a 1-7 scale (1 = extremely unlikely to use \| 7 = extremely likely to use). Higher scores indicate higher use intentions. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/

Secondary

MeasureTime frameDescription
Patient SatisfactionImmediately upon completion of the primary measures.Patient satisfaction with the health questionnaire will be measured using an intervention-tailored version of the Clinical Use Satisfaction Scale. The modified version is a 14-item measure utilizing two 1-7 rating scales. Items 1 - 12 use the following rating scale: 1 = strongly disagree \| 7 = strongly agree. Items 13 - 14 use the scale: 1 = very unlikely \| 7 = very likely. Higher scores indicate greater satisfaction with the health questionnaire. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: Zimmerman, M., Gazarian, D., Multach, M., Attiullah, N., Benoff, T., Boerescu, D. A., ... & Holst, C. G. (2017). A clinically useful self-report measure of psychiatric patients' satisfaction with the initial evaluation. Psychiatry research, 252, 38-44.

Countries

United States

Contacts

Primary ContactSarah E Hill, PhD
s.e.hill@tcu.edu8172576424
Backup ContactSummer Mengelkoch, MS
s.mengelkoch@tcu.edu817-257-4898

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026